We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.62B
AUM Growth
+$482M
(+5.3%)
Cap. Flow
+$328M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
35.81%
Holding
1,132
New
163
Increased
147
Reduced
109
Closed
164
Avg Time Held Equity + Options
2.6
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.6
quarters
Avg Time Held Equity only
2.6
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$454M |
| 2 |
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$312M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$286M |
| 4 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$248M |
| 5 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$829M |
| 2 |
MIME
Mimecast Limited
MIME
|
+$351M |
| 3 |
PLAN
Anaplan, Inc.
PLAN
|
+$325M |
| 4 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$260M |
| 5 |
VNE
Veoneer, Inc.
VNE
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.77% |
| 2 | Financials | 20.95% |
| 3 | Industrials | 11.05% |
| 4 | Real Estate | 10.82% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Phathom Pharmaceuticals
PHAT
$576M
| $1.07M | 0.01% |
127,093
+89,591
| +239% | +$921K |
2022 Q1
1 quarter
|
|
727
SHF Holdings
SHFS
$418K
| $1.07M | 0.01% |
421
| – | – |
2021 Q3
3 quarters
|
|
|
ISEE
728
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.06M | 0.01% |
+109,750
| New | +$1.38M |
2022 Q2
0 quarters
|
|
729
Getty Realty Corp
GTY
$1.74B
| $1.04M | 0.01% |
+39,281
| New | +$1.07M |
2022 Q2
0 quarters
|
|
|
PIPP
730
DELISTED
Pine Island Acquisition Corp.
PIPP
| $1.04M | 0.01% |
105,013
| – | – |
2021 Q1
5 quarters
|
|
731
DELISTED
Blueprint Medicines
BPMC
| $1.03M | 0.01% |
20,390
+4,390
| +27% | +$257K |
2022 Q1
1 quarter
|
|
|
RACB
732
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $1.03M | 0.01% |
105,005
| – | – |
2021 Q4
2 quarters
|
|
733
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $1.03M | 0.01% |
102,949
| – | – |
2022 Q1
1 quarter
|
|
734
Karyopharm Therapeutics
KPTI
$11.5M
| $1.03M | 0.01% |
15,173
+8,506
| +128% | +$780K |
2022 Q1
1 quarter
|
|
|
ASAX
735
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
| $1.03M | 0.01% |
105,005
| – | – |
2021 Q3
3 quarters
|
|
736
CME Group
CME
$99.6B
| $1.02M | 0.01% |
+5,000
| New | +$1.06M |
2022 Q2
0 quarters
|
|
|
HWEL
737
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
| $1.02M | 0.01% |
105,005
| – | – |
2021 Q4
2 quarters
|
|
738
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
| $1.01M | 0.01% |
+102,949
| New | +$1.01M |
2022 Q2
0 quarters
|
|
|
ACAH
739
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
| $1.01M | 0.01% |
102,949
| – | – |
2021 Q4
2 quarters
|
|
740
Edgewise Therapeutics
EWTX
$4.17B
| $995K | 0.01% |
+125,000
| New | +$945K |
2022 Q2
0 quarters
|
|
741
DELISTED
HilleVax
HLVX
| $994K | 0.01% |
+90,943
| New | +$1.08M |
2022 Q2
0 quarters
|
|
742
Ford
F
$47.8B
| $991K | 0.01% |
+89,064
| New | +$1.22M |
2022 Q2
0 quarters
|
|
743
Shoals Technologies Group
SHLS
$1.45B
| $989K | 0.01% |
+59,985
| New | +$886K |
2022 Q2
0 quarters
|
|
744
Monte Rosa Therapeutics
GLUE
$896M
| $983K | 0.01% |
101,647
+34,647
| +52% | +$348K |
2022 Q1
1 quarter
|
|
745
Brookfield Renewable
BEPC
$5.43B
| $978K | 0.01% |
+27,473
| New | +$1.02M |
2022 Q2
0 quarters
|
|
746
Lennox International
LII
$12.4B
| $969K | 0.01% |
+4,691
| New | +$1.03M |
2022 Q2
0 quarters
|
|
747
Bicycle Therapeutics
BCYC
$265M
| $967K | 0.01% |
57,625
+32,625
| +131% | +$688K |
2022 Q1
1 quarter
|
|
748
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $965K | 0.01% |
+85,050
| New | +$1.25M |
2022 Q2
0 quarters
|
|
749
Fluence Energy
FLNC
$1.01B
| $948K | 0.01% |
100,000
+10,000
| +11% | +$97.3K |
2021 Q4
2 quarters
|
|
750
SCYNEXIS
SCYX
$40.3M
| $942K | 0.01% |
+63,280
| New | +$1.22M |
2022 Q2
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q2 2022 Portfolio in Review
As of Q2 2022, UBS O'Connor held 1,132 positions worth $9.62B, up 5.3% from $9.14B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
UBS O'Connor deployed $328M of net new capital in Q2 2022, opening 163 new positions and adding to 147 existing holdings. Its largest new stake was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Occidental Petroleum Corp Warrants, an estimated $15.7M trimmed.
- UBS O'Connor's largest Q2 2022 buy was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
- UBS O'Connor added most to Mandiant, Inc. Common Stock in Q2 2022, an estimated $220M increase.
- UBS O'Connor's biggest Q2 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $15.7M.
- UBS O'Connor fully exited Cerner Corp in Q2 2022, selling an estimated $829M.
- UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
- UBS O'Connor opened 163 new positions and closed 164 in Q2 2022.
- UBS O'Connor's portfolio value rose 5.3% quarter-over-quarter to $9.62B.
Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.